Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strain
- PMID: 22761799
- PMCID: PMC3383706
- DOI: 10.1371/journal.pone.0039451
Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strain
Abstract
Acinetobacter baumannii has been identified by the Infectious Diseases Society of America as one of the six pathogens that cause majority of hospital infections. Increased resistance of A.baumannii even to the latest generation of β-lactams like carbapenem is an immediate threat to mankind. As inner-membrane fraction plays a significant role in survival of A.baumannii, we investigated the inner-membrane fraction proteome of carbapenem-resistant strain of A.baumannii using Differential In-Gel Electrophoresis (DIGE) followed by DeCyder, Progenesis and LC-MS/MS analysis. We identified 19 over-expressed and 4 down-regulated proteins (fold change>2, p<0.05) in resistant strain as compared to reference strain. Some of the upregulated proteins in resistant strain and their association with carbapenem resistance in A.baumannii are: i) β-lactamases, AmpC and OXA-51: cleave and inactivate carbapenem ii) metabolic enzymes, ATP synthase, malate dehydrogenase and 2-oxoglutarate dehydrogenase: help in increased energy production for the survival and iii) elongation factor Tu and ribosomal proteins: help in the overall protein production. Further, entry of carbapenem perhaps is limited by controlled production of OmpW and low levels of surface antigen help to evade host defence mechanism in developing resistance in A.baumannii. Present results support a model for the importance of proteins of inner-membrane fraction and their synergistic effect in the mediation of resistance of A.baumannii to carbapenem.
Conflict of interest statement
Figures


Similar articles
-
Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India.Microb Pathog. 2012 Aug;53(2):81-6. doi: 10.1016/j.micpath.2012.05.004. Epub 2012 May 17. Microb Pathog. 2012. PMID: 22610043
-
Molecular characteristics of carbapenem-resistant Acinetobacter spp. from clinical infection samples and fecal survey samples in Southern China.BMC Infect Dis. 2019 Oct 28;19(1):900. doi: 10.1186/s12879-019-4423-3. BMC Infect Dis. 2019. PMID: 31660862 Free PMC article.
-
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.Microb Pathog. 2019 Mar;128:75-81. doi: 10.1016/j.micpath.2018.12.023. Epub 2018 Dec 15. Microb Pathog. 2019. PMID: 30562602
-
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.Clin Microbiol Infect. 2006 Sep;12(9):826-36. doi: 10.1111/j.1469-0691.2006.01456.x. Clin Microbiol Infect. 2006. PMID: 16882287 Review.
-
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management.Expert Rev Anti Infect Ther. 2013 Apr;11(4):383-93. doi: 10.1586/eri.13.14. Expert Rev Anti Infect Ther. 2013. PMID: 23566148 Review.
Cited by
-
iTRAQ-Based Quantitative Proteomic Analysis of Acinetobacter baumannii under Hypoxia and Normoxia Reveals the Role of OmpW as a Virulence Factor.Microbiol Spectr. 2022 Apr 27;10(2):e0232821. doi: 10.1128/spectrum.02328-21. Epub 2022 Mar 2. Microbiol Spectr. 2022. PMID: 35234505 Free PMC article.
-
Outer Membrane Porins Contribute to Antimicrobial Resistance in Gram-Negative Bacteria.Microorganisms. 2023 Jun 28;11(7):1690. doi: 10.3390/microorganisms11071690. Microorganisms. 2023. PMID: 37512863 Free PMC article. Review.
-
Epitope mapping of Acinetobacter baumannii outer membrane protein W (OmpW) and laboratory study of an OmpW-derivative peptide.Heliyon. 2023 Jul 25;9(8):e18614. doi: 10.1016/j.heliyon.2023.e18614. eCollection 2023 Aug. Heliyon. 2023. PMID: 37560650 Free PMC article.
-
Characterization of carbapenem-resistant Acinetobacter baumannii isolates in a Chinese teaching hospital.Front Microbiol. 2015 Sep 1;6:910. doi: 10.3389/fmicb.2015.00910. eCollection 2015. Front Microbiol. 2015. PMID: 26388854 Free PMC article.
-
Proteomics in India: the clinical aspect.Clin Proteomics. 2016 Nov 5;13:21. doi: 10.1186/s12014-016-9122-0. eCollection 2016. Clin Proteomics. 2016. PMID: 27822170 Free PMC article. Review.
References
-
- Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46:1254–1263. - PubMed
-
- Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis. 2008;8:751–762. - PubMed
-
- Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez FJ, Perez-Paredes C. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis. 2001;33:939–946. - PubMed
-
- Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez FJ, Monterrubio-Villar J. Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med. 1999;27:1794–1799. - PubMed
-
- Suri A, Mahapatra AK, Kapil A. Acinetobacter infection in neurosurgical intensive care patients. Natl Med J India. 2000;13:296–300. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials